Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Clinical Therapeutics|April 1, 2000
Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foodsA H Chun, K Erdman, Y Zhang, et al.Journal of Clinical Pharmacology|July 1, 1994
Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variationZ Hussein, D Mukherjee, J Lamm, et al.Therapeutic Drug Monitoring|October 1, 1995
Pharmacokinetic interaction between lansoprazole and theophyllineG R Granneman, M D Karol, C S Locke, et al.The Journal of Clinical Psychiatry|May 1, 1996
Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodiumG R Granneman, D W Schneck, J H Cavanaugh, et al.Clinical Therapeutics|September 1, 1996
Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tubeA H Chun, H H Shi, R Achari, et al.American Journal of Therapeutics|March 31, 1999
Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophyllineS L Wong, J H Cavanaugh, J Qian, et al.Clinical Pharmacokinetics|January 1, 1995
The effect of food on the pharmacokinetics of zileutonW M Awni, J H Cavanaugh, G Witt, et al.Clinical Pharmacokinetics|January 1, 1995
Assessment of the pharmacokinetic interaction between zileuton and digoxin in humansW M Awni, Z Hussein, J H Cavanaugh, et al.Biopharmaceutics & Drug Disposition|July 1, 1993
Effect of infusion duration on valproate pharmacokineticsZ Hussein, K J Patterson, J E Lamm, et al.Journal of Clinical Pharmacology|August 1, 1990
Absorption characteristics of a new valproate formulation: divalproex sodium-coated particles in capsules (Depakote Sprinkle)P J Carrigan, D R Brinker, J H Cavanaugh, et al.Pageof 4